2019 News

Keyword Search
 
2019 | 2018 | 2017 | 2016 | 2015
DateTitle 
03/18/19IRIDEX to Present at the Spring Investor Summit
MOUNTAIN VIEW, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to present at the upcoming Spring Investor Summit in New York, NY. Chairman and CEO William Moore is scheduled to present on Monday, April 1, 2019 at 3:00 PM ET.  Interested parties may access a live and archived webcast of the presentation at www.IRIDEX.com. About IRIDEX IRIDEX Corporation is a worldwide leader in developing, manufacturing, and marketing innovativ... 
Printer Friendly Version
03/06/19IRIDEX to Present at the 31st Annual Roth Conference
MOUNTAIN VIEW, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to present at the upcoming 31st Annual Roth Conference in Orange County, CA. Management is scheduled to present on Tuesday, March 19, 2019 at 9:00 AM PT.  Interested parties may access a live and archived webcast of the presentation at www.IRIDEX.com. About IRIDEX IRIDEX Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and ve... 
Printer Friendly Version
03/05/19IRIDEX Announces 2018 Fourth Quarter and Full Year Financial Results
MOUNTAIN VIEW, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter and year ended December 29, 2018. Fourth Quarter Highlights Cyclo G6® product revenue increased approximately 16% year-over-year Shipped a record 12,300 Cyclo G6 probes Shipped 122 Cyclo G6 Glaucoma Laser Systems Revenue of $11.5 million, a 12% increase year-over-year “I am pleased with the accomplishments of our team in 2018.... 
Printer Friendly Version
02/26/19IRIDEX to Report Fourth Quarter and 2018 Financial Results on March 5, 2019
MOUNTAIN VIEW, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the fourth quarter and full year 2018 after the close of trading on Tuesday, March 5, 2019.  The Company’s management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-3030 for ... 
Printer Friendly Version
02/12/19IRIDEX Announces Resolution of its Dispute with Quantel Medical
MOUNTAIN VIEW, Calif., Feb. 12, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it has resolved its differences with Quantel Medical, S.A., Quantel USA, Inc., and Quantel, S.A. (collectively, “Quantel”) in its lawsuit filed against Quantel in the U.S. District Court for the Northern District of California. IRIDEX dismissed the lawsuit it had filed in January 2018, alleging that Quantel products infringed IRIDEX’s U.S. Patent No. 7,771,417, that Quantel breached ... 
Printer Friendly Version
01/08/19IRIDEX Announces Preliminary Operational and Financial Results for 2018 Fourth Quarter and Full Year
MOUNTAIN VIEW, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today provided preliminary operational and financial results for the fourth quarter and full year ended December 29, 2018. Highlights Shipped approximately 460 to 465 Cyclo G6® Glaucoma Laser Systems and 45,500 to 46,500 G6 probes in the full year 2018 Shipped approximately 119 to 124 Cyclo G6® Glaucoma Laser Systems and a record 12,000 to 13,000 G6 probes in the fourth quarter 2018 Total r... 
Printer Friendly Version


logo aa0logo agslogo ascrslogo asrslogo esrs0logo euretina